1. Home
  2. Investing
  3. Stocks
  4. USA
  6. Xeris Biopharma Holdings Inc (XERS)
  7. Quote


Xeris Biopharma Stock Price

0.03 (1.5%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 1,550,198
Bid Price 2.03
Ask Price 2.05
News -
Day High 2.05


52 Week Range


Day Low 1.96
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Xeris Biopharma Holdings Inc XERS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.03 1.5% 2.03 17:22:04
Open Price Low Price High Price Close Price Prev Close
2.01 1.96 2.05 2.04 2.00
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
4,628 1,550,198 $ 2.01 $ 3,116,630 - 1.77 - 7.94
Last Trade Time Type Quantity Stock Price Currency
17:31:28 10 $ 2.03 USD


Draw Mode:

Xeris Biopharma Holdings Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 253.16M 124.71M 123.90M $ 20.44M $ - -2.23 -1.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 2.28M 2.10%

more financials information »

Xeris Biopharma News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical XERS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.102.231.9352.041,337,265-0.07-3.33%
1 Month1.942.621.892.232,216,9620.094.64%
3 Months2.632.771.772.171,765,379-0.60-22.81%
6 Months3.254.981.772.983,222,039-1.22-37.54%
1 Year4.187.941.773.752,795,611-2.15-51.44%
3 Years21.1221.341.424.121,570,961-19.09-90.39%
5 Years15.7527.98261.424.271,379,608-13.72-87.11%

Xeris Biopharma Description

Xeris Biopharma Holdings Inc is a biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology, neurology, and gastroenterology. The company have two commercially available products, Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia and Keveyis, the first and only FDA-approved therapy for primary periodic paralysis.

Your Recent History
Xeris Biop..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.